This study is for people who have previously used A2 Bio gene therapy (GT) products in another study. Gene therapy is a way to treat diseases by changing the genes inside your body's cells. The goal is to keep track of any late safety issues and see how effective the treatment is over a long time. Participants will be monitored for up to 15 years after they received the A2 Bio GT product, but there will be no more treatments given in this study.
- The study requires a commitment of 15 years for follow-up.
- Participants need to have completed a previous study with A2 Bio GT products.
- There are no specific reasons to be excluded from this study.
Participants must be able to understand and sign a consent form and follow the study rules. The study ensures long-term safety by keeping in line with FDA guidelines.
How understandable was the trial content above?
Hard to understand
Easy to understand